GENX.US Genex Pharmaceutical Inc
- Market cap
- -
- P/E
- -
- P/B
- 0.08x
- ROE
- 7.2%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2007.
Is GENX.US undervalued?
Graham numberThe Graham number of Genex Pharmaceutical Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Genex Pharmaceutical Inc fundamental analysis
No fundamental analysis for Genex Pharmaceutical Inc yet.
Genex Pharmaceutical Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Genex Pharmaceutical Inc
Genex Pharmaceutical, Inc. produces and distributes Reconstituted Bone Xenograft (RBX) in the People's Republic of China. The RBX is a medical device that accelerates bone healing. The company distributes its medical devices to approximately 500 hospitals, as well as to other medical device customers. Genex Pharmaceutical, Inc. was founded in 2003 and is headquartered in Tianjin, the People's Republic of China.
Full company profileGenex Pharmaceutical Inc financial statements
Genex Pharmaceutical Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2003 | 2004 | 2005 | 2006 | 2007 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 3.48K | 2.35M | 2.49M | 2.44M | 3.24M |
| Gross Profit | -301.00 | 2.07M | 2.19M | 2.22M | 2.87M |
| Operating Income | 52.3K | 992K | 921K | 847K | 466K |
| EBITDA | -48.9K | 1.05M | 980K | 903K | 790K |
| Net Income | -52.3K | 1.01M | 625K | 619K | 343K |
| EPS | 0.00 | 0.06 | 0.04 | 0.03 | 0.02 |
| Balance Sheet | |||||
| Total Assets | 22.1K | 2.94M | 4.42M | 5.74M | 8.65M |
| Total Liabilities | 9.01K | 326K | 1.11M | 1.68M | 3.91M |
| Shareholders' Equity | 13.1K | 2.61M | 3.32M | 4.07M | 4.74M |
| Cash & Short-term Investments | 10.2K | 326K | 296K | 192K | 430K |
| Cash Flow | |||||
| Operating Cash Flow | -41.7K | 90.0K | 1.38M | 1.18M | 530K |
| Capital Expenditure | 3.03K | 6.11K | 1.50K | 3.54K | 1.25K |
| Free Cash Flow | -44.7K | 83.9K | 1.38M | 1.18M | 528K |
| Ratios | |||||
| ROE | -400.1% | 38.8% | 18.8% | 15.2% | 7.2% |
| ROA | -236.8% | 34.5% | 14.1% | 10.8% | 4.0% |
| Net Profit Margin | -1,500.3% | 43.1% | 25.1% | 25.4% | 10.6% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Genex Pharmaceutical Inc dividends
Genex Pharmaceutical Inc has not paid dividends in the last 5 fiscal years.
Last stock split: 4:1 on Jul 1, 2004.
Who owns Genex Pharmaceutical Inc
- Insiders 0.01%
- Institutions 0.00%
- Public & others 99.99%
Genex Pharmaceutical Inc company profile
- Company name
- Genex Pharmaceutical Inc
- Ticker
- GENX.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Employees
- 86
- Fiscal year end
- December
- Address
- 1801 Guangyin Building, Tianjin, China, 300074
- Phone
- 86 22 2337 0440
- Website
- -
About Genex Pharmaceutical Inc
Genex Pharmaceutical, Inc. produces and distributes Reconstituted Bone Xenograft (RBX) in the People's Republic of China. The RBX is a medical device that accelerates bone healing. The company distributes its medical devices to approximately 500 hospitals, as well as to other medical device customers. Genex Pharmaceutical, Inc. was founded in 2003 and is headquartered in Tianjin, the People's Republic of China.
Genex Pharmaceutical Inc management
2- Mr. Fuzhi SongChairman, Chief Executive Officer, President and Chairman of Zhongjin Biology Development Co. Ltd · born 1952
- Mr. Shuli Zhang CPA, CPV, CTACFO, Principal Accounting Officer, Treasurer and CFO of Zhongjin · born 1962